Structure base drug discovery company
Amura Holdings Ltd., Minerva Building, Babraham Research Campus, Babraham, CB22 3AT, U.K.
Home
Company
Board of Directors
Senior Management
Company Information
Licensing
Disclaimer
Technologies
Programmes
Contact
Sitemap
Search
 
 
     
 

Company Information

Amura Holdings Limited is a private company funded by venture capital.  Amura Holdings Limited (No. 5471986) is the parent company of a number of wholly-owned subsidiaries including Amura Therapeutics Limited (No. 04046951), Amura Technologies Limited (No. 3843539) and Amura Limited (No. 3277080).  Our Registered Offices are at Highfield Court, Church Lane, Madingley, Cambridgshire, CB23 8AG, U.K.

Our main investors are Avlar BioVentures and Noble Group. For more details on our main investors please visit:

Avlar BioVentures
Tel: +44(0)1954 211 515
FAX: +44(0)1223 211 516
Email:
avlar@avlar.com
http://www.avlar.com/


Noble Group
Tel: +44(0)20 7763 2200
FAX: +44(0)20 7763 2399
Email:
noble@noblegp.com
http://www.noblegp.com/

 

 
     
Email: amura@amura.co.uk
Phone: +44(0)1223 839797 Fax: +44(0)1223 839898 Copyright © 2008 Amura Holdings Ltd.